Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition.

[1]  Y Pawitan,et al.  Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer , 2013, Oncogene.

[2]  E. Martin,et al.  Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration , 2012, Breast Cancer Research.

[3]  A. Hill,et al.  Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. , 2012, Cancer research.

[4]  P. V. van Diest,et al.  Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha , 2011, Oncogene.

[5]  U. Gündüz,et al.  Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Hoo-Kyun Choi,et al.  Involvement of Pin1 induction in epithelial–mesenchymal transition of tamoxifen‐resistant breast cancer cells , 2009, Cancer science.

[7]  Robert L. Sutherland,et al.  Biological determinants of endocrine resistance in breast cancer , 2009, Nature Reviews Cancer.

[8]  Ben S. Wittner,et al.  Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor , 2009, Proceedings of the National Academy of Sciences.

[9]  R. Nicholson,et al.  Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation , 2006, International journal of cancer.